Moxibustion head points based on cerebrospinal fluid of patients with vascular dementia of somatostatin and arginine vasopressin levels of the randomized controlled trials.doc

 PAGE \* MERGEFORMAT 18 Moxibustion head points based on cerebrospinal fluid of patients with vascular dementia of somatostatin and arginine vasopressin levels of the randomized controlled trials Of: Wang Pin, Yang Jun, Liu Gang, Chen Hao, Fan Yang [Abstract] BACKGROUND: Vascular dementia (vascular dementia, VaD patients with a variety of plasma and cerebrospinal fluid neuropeptides in the apparent material change, the effective intervention of neuropeptide levels, the prevention and treatment of VaD is very important. Objective: To moxibustion head Treatment of the Ministry of points VaD, improve clinical symptoms observed in cerebrospinal fluid and regulation of learning and memory associated with the substance of neuropeptide somatostatin (somatostatin, SS and arginine vasopressin (arginine vasopressin, AVP level role. design setting, participants and interventions: 65 patients with VaD patients were Anhui Traditional Chinese Medical acupuncture clinic or hospital inpatients. by randomly divided into the moxibustion group (33 cases and western medicine group (32 cases. moxibustion group were treated every Aconite cake pressure moxibustion, moxibustion repeated 20 min, western group was treated with Piracetam tablets 0.8 g, 3 times / d. Both groups were treated for 4 cycles, 4 weeks for a course of treatment. Main outcome measures: two groups were compared before and after treatment Hasegawa Dementia Scale Smart Check (Hasegawa’s Dementia Scale, HDS, mini mental mental state examination (Mini Mental State Examination, MMSE and ADL (Activity of Daily Living Scale, ADL points change, and cerebrospinal fluid in the SS and AVP levels. Results: The total efficiency and moxibustion medicine group, the difference was statistically significant (P lt;0.01. the two groups before and after treatment HDS, MMSE and ADL points, the difference was significant (P lt;0.05, P lt;0.01, moxibustion group HDS, MMSE and ADL scale score difference before and after treatment h